HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
National Institutes of Health
About this archived opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.
Historical details
- Status
- Closed
- Deadline
- March 13, 2026
- First captured
- December 17, 2025
- Award
- $2,500,000
- Publisher reference
- 350461
Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
This opportunity has closed
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new vaccine, research, design opportunities are posted. Free.